Latest news

New drug for Stargardt could reach patients faster

Posted: Friday 17 June 2022 at 08:39

A new drug to treat Stargardt disease has been granted a fast-track review by the Food and Drug Administration in the US, to help make it available to patients quicker.

Find out more

Eye drops being instilled into patient by professional with blue gloves.

New treatment approved for wet AMD and diabetic macular oedema

Posted: Tuesday 24 May 2022 at 09:00

A new treatment for wet AMD and diabetic macular oedema Faricimab has been approved for use on the NHS in England.

Find out more

Eye health experts to review research priorities

Posted: Tuesday 17 May 2022 at 15:14

Eye experts across the UK are calling for input to refresh research priorities for patients, relatives, carers and eye health professionals.

Find out more

New research could lead to a treatment for both wet and dry AMD

Posted: Tuesday 17 May 2022 at 14:02

Scientists at The University of Manchester have identified those who are at risk of developing AMD, based on their genes, and discovered underlying changes in the tissue of these otherwise healthy individuals.

Find out more

New chatbot offering timely advice to patients

Posted: Friday 29 April 2022 at 16:16

A virtual rehabilitation assistant could offer timely, relevant information and advice to people with visual impairments.

Find out more

Researcher hopes gene editing technique could treat Stargardt disease

Posted: Tuesday 5 April 2022 at 09:23

A researcher looking into the possibility of correcting the faulty gene that causes Stargardt disease has spoken about her groundbreaking project.

Find out more

Drug trial for dry AMD slows progression of disease

Posted: Tuesday 29 March 2022 at 10:03

A drug being trialled for dry age-related macular degeneration (AMD) can significantly reduce the progression of the disease, according to new studies.

Find out more

Researcher in lab

Researchers reveal more about potential new drug for AMD

Posted: Monday 28 March 2022 at 13:45

Researchers at Queen Mary University London who are working on a new treatment that could stop dry age-related macular degeneration (AMD) developing into wet will reveal more detail about the drug in April.

Find out more